Suchen und filtern

Gefundene Studien

NEOBRAF Neoadjuvant encorafenib, binimetinib and cetuximab for patients with BRAF mutated/pMMR localized colorectal cancer - AIO Phase II trial AIO-KRK-0420 · In Rekrutierung Studie anzeigen

CIRCULATE Circulating tumor DNA based decision for adjuvant treatment in colon cancer stage II evaluation AIO-KRK-0217 · In Rekrutierung Studie anzeigen

NEOBIL Neoadjuvant bintrafusp alfa in patients with resectable biliary tract cancer AIO-HEP-0120 · Rekrutierung beendet Studie anzeigen

Re-Check Randomized phase II, open-label efficacy and safety study of second-line durvalumab plus tremelimumab versus platinum-based chemotherapy alone in patients with NSCLC and first-line checkpoint-inhibitor therapy followed by 2 cycles of platinum-based chemotherapy AIO-TRK-0221 · Studie beendet Studie anzeigen

PHERFLOT Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma - A phase II trial of the AIO study group AIO-STO-0321 · In Vorbereitung Studie anzeigen

INTEGRATE IIb Randomized Phase III Controlled Trials of Regorafenib containing regimens versus standard care in Refractory Advanced Gastro-Oesophageal Cancer (AGOC) - INTEGRATE IIb AIO-STO-0221/ass · In Rekrutierung Studie anzeigen

POLESTAR Phase IIA trial of short-term chemotherapy and pembrolizumab, followed by Pembrolizumab and OLaparib as firstline therapy in Her-2 negative gastric/gastroESophageal-juncTion (GEJ) AdenocaRcinoma AIO-STO-0121/ass · In Rekrutierung Studie anzeigen

METAPANC Intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone: a randomized controlled phase 3 trial (METAPANC) AIO-PAK-0219 · In Vorbereitung Studie anzeigen

ESPAC-6 An open labelled phase III adjuvant trial of disease-free survival in patients with resected pancreatic ductal adenocarcinoma randomized to allocation of oxaliplatin- or gemcitabine-based chemotherapy by standard clinical criteria or by a transcriptomic treatment specific stratification signature - ESPAC-6 AIO-PAK-0121/ass · In Vorbereitung Studie anzeigen

ANTONIO Perioperative/Adjuvant atezolizumab with or without the immunomodulatory IMM-101 in patients with MSI-high or MMR-deficient stage III colorectal cancer ineligible for oxaliplatin-based chemotherapy– a randomized Phase II study AIO-KRK-0220 · In Rekrutierung Studie anzeigen